PRODUCTS

AIMAFIX 500 IU / 10 mL



Active Ingredient: Factor IX
Indication: Factor IX deficiency (Hemophilia B)
Pharmaceutical Form: Powder and solvent for IV infusion

ANDRAXAN 250 mg



Active Ingredient: Flutamid
Indication: Malignant diseases
Pharmaceutical Form: Tablet

ALOXI 250 μg/5ml



Active Ingredient: Palonosetron
Indication: Malignant diseases
Pharmaceutical Form: Solution for IV

ARİSTU 1 mg



Active Ingredient: Anastrozol
Indication: Malignant diseases
Pharmaceutical Form: Tablet

BLEOCIN-S 15 mg



Active Ingredient: Bleomycin
Indication: Malignant diseases
Pharmaceutical Form: Powder and solvent for IM, IV, IA

BOREA 160 mg



Active Ingredient: Megestrol acetate
Indication: Malignant diseases
Pharmaceutical Form: Tablet

EMOCLOT 1000 IU / 10 mL



Active Ingredient: Factor VIII
Indication: Factor VIII deficiency (Hemophilia A)
Pharmaceutical Form: Powder and solvent for IV infusion

EMOCLOT 500 IU / 10 mL



Active Ingredient: Factor VIII
Indication: Factor VIII deficiency (Hemophilia A)
Pharmaceutical Form: Powder and solvent for IV infusion

EXETU 25 mg



Active Ingredient: Exemestane
Indication: Malignant diseases
Pharmaceutical Form: Tablet

Ig VENA 10 g/ 200 mL



Active Ingredient: Human immunoglobulin
Indication: Blood derivative
Pharmaceutical Form: Solution for IV

Ig VENA 5g/ 100 mL



Active Ingredient: Human immunoglobulin
Indication: Blood derivative
Pharmaceutical Form: Solution for IV

Ig VENA 2,5g/ 50 mL



Active Ingredient: Human immunoglobulin
Indication: Blood derivative
Pharmaceutical Form: Solution for IV

Ig VENA 1 g/ 20 mL



Active Ingredient: Human immunoglobulin
Indication: Blood derivative
Pharmaceutical Form: Solution for IV

IMMUNORHO 300 mg (1500 IU)/2m



Active Ingredient: Human anti-D immunoglobulin
Indication: Blood derivative
Pharmaceutical Form: Solution for IV

İRONTU 100 mg/5 ml



Active Ingredient: Irinotecan
Indication: Malignant diseases
Pharmaceutical Form: Solution for IV

İRONTU 40 mg/2 ml



Active Ingredient: Irinotecan
Indication: Malignant diseases
Pharmaceutical Form: Solution for IV

LASTET 100mg amp



Active Ingredient: Etoposide
Indication: Malignant diseases
Pharmaceutical Form: Capsule, and Solution for IV

LASTET 100mg 10 caps



Active Ingredient: Etoposide
Indication: Malignant diseases
Pharmaceutical Form: Capsule, and Solution for IV

LASTET 50mg 20 caps



Active Ingredient: Etoposide
Indication: Malignant diseases
Pharmaceutical Form: Capsule, and Solution for IV

LASTET 25mg 40 caps



Active Ingredient: Etoposide
Indication: Malignant diseases
Pharmaceutical Form: Capsule, and Solution for IV

LETU 2,5 mg



Active Ingredient: Letrozole
Indication: Malignant diseases
Pharmaceutical Form: Tablet

METOJECT 10 mg



Active Ingredient: Methotrexate
Indication: Antiinflammatory
Pharmaceutical Form: Prefilled syringe

METOJECT 15 mg



Active Ingredient: Methotrexate
Indication: Antiinflammatory
Pharmaceutical Form: Prefilled syringe

METOJECT 20 mg



Active Ingredient: Methotrexate
Indication: Antiinflammatory
Pharmaceutical Form: Prefilled syringe

METOJECT 25 mg



Active Ingredient: Methotrexate
Indication: Antiinflammatory
Pharmaceutical Form: Prefilled syringe

MITOMYCIN-C 2 mg inj.



Active Ingredient: Mitomycin-C
Indication: Malignant diseases
Pharmaceutical Form: Solution for IV

MITOMYCIN-C 10 mg inj.



Active Ingredient: Mitomycin-C
Indication: Malignant diseases
Pharmaceutical Form: Solution for IV

MITOMYCIN-C 20 mg inj.



Active Ingredient: Mitomycin-C
Indication: Malignant diseases
Pharmaceutical Form: Solution for IV

UMAN ALBUMIN %20 100 ml 50 mL



Active Ingredient: Human albumin
Indication: Malignant diseases
Pharmaceutical Form: Solution for injection

UMAN ALBUMIN %20 100 ml 100 mL



Active Ingredient: Human albumin
Indication: Malignant diseases
Pharmaceutical Form: Solution for injection

Cisplatinum Onko İnjection 10 mg/20 ml



Active Ingredient: Cisplatinium
Indication: Malignant diseases
Pharmaceutical Form: Powder and solvent for IV infusion

Cisplatinum Onko İnjection 25 mg/50 ml



Active Ingredient: Cisplatinium
Indication: Malignant diseases
Pharmaceutical Form: Powder and solvent for IV infusion

Cisplatinum Onko İnjection 50 mg/100 ml



Active Ingredient: Cisplatinium
Indication: Malignant diseases
Pharmaceutical Form: Powder and solvent for IV infusion

GEMTU 1000 mg /10 ml



Active Ingredient: Gemcitabine
Indication: Malignant diseases
Pharmaceutical Form: Solution for infusion

CARPLATU 450 mg/45 ml



Active Ingredient: Carplatinium
Indication: Malignant diseases
Pharmaceutical Form: Solution for IV

OXATU 50 mg



Active Ingredient: Oxaliplatin
Indication: Malignant diseases
Pharmaceutical Form: Solution for IV

Oxatu-S 50 mg/10 ml



Active Ingredient: Oxaliplatin
Indication: Malignant diseases
Pharmaceutical Form: Solution for IV

Oxatu-S 100 mg/20 ml



Active Ingredient: Oxaliplatin
Indication: Malignant diseases
Pharmaceutical Form: Solution for IV

Casomid 50 mg



Active Ingredient: Bicalutamide
Indication: Malignant diseases
Pharmaceutical Form: Tablet

Epiritu 50 mg/25 ml



Active Ingredient: Epirubicin
Indication: Malignant diseases
Pharmaceutical Form: Solution for IV

Mextu 50 mg/2 ml



Active Ingredient: Methotrexate
Indication: Malignant diseases
Pharmaceutical Form: Solution for infusion (IM, IA, IV, IT)

Pramitu 0.25 mg



Active Ingredient: Pramipexole
Indication: Systema Nervosum
Pharmaceutical Form: Tablet

Pramitu 1 mg



Active Ingredient: Pramipexole
Indication: Systema Nervosum
Pharmaceutical Form: Tablet

Epiritu 200 mg/100 ml



Active Ingredient: Epirubicin
Indication: Malignant diseases
Pharmaceutical Form: Solution for IV

Tacritu 0.5 mg



Active Ingredient: Tacrolimus
Indication: Malignant diseases
Pharmaceutical Form: Capsule

Tacritu 1 mg



Active Ingredient: Tacrolimus
Indication: Malignant diseases
Pharmaceutical Form: Capsule

Tacritu 5 mg



Active Ingredient: Tacrolimus
Indication: Malignant diseases
Pharmaceutical Form: Capsule

Gemtu 2000 mg/20 ml



Active Ingredient: Gemcitabine
Indication: Malignant diseases
Pharmaceutical Form: Solution for infusion

Epiritu 10 mg/5 ml



Active Ingredient: Epirubicin
Indication: Malignant diseases
Pharmaceutical Form: Solution for IV

Topotu 4 mg/4 ml



Active Ingredient: Topotecan
Indication: Malignant diseases
Pharmaceutical Form: Solution for IV

Gemtu 200 mg/2 ml



Active Ingredient: Gemcitabine
Indication: Malignant diseases
Pharmaceutical Form: Solution for infusion

5-Frotu 1000 mg/20 ml



Active Ingredient: 5-Fluoracil
Indication: Malignant diseases
Pharmaceutical Form: Solution for IV

5-Frotu 5000 mg/100 ml



Active Ingredient: 5-Fluoracil
Indication: Malignant diseases
Pharmaceutical Form: Solution for IV

Doxtu 10 mg/5 ml



Active Ingredient: Doxorubicin
Indication: Malignant diseases
Pharmaceutical Form: Solution for IV

Doxtu 50 mg/25 ml



Active Ingredient: Doxorubicin
Indication: Malignant diseases
Pharmaceutical Form: Solution for IV

Carplatu 50 mg/5 ml



Active Ingredient: Carplatinium
Indication: Malignant diseases
Pharmaceutical Form: Solution for IV

Carplatu 150 mg/15 ml



Active Ingredient: Carplatinium
Indication: Malignant diseases
Pharmaceutical Form: Solution for IV

Zomtu 4 mg/5 ml



Active Ingredient: Zoledronic acid
Indication: Malignant diseases, Hypercalcemia
Pharmaceutical Form: Solution for injection

Zomtu 4 mg/100 ml



Active Ingredient: Zoledronic acid
Indication: Malignant diseases, Hypercalcemia
Pharmaceutical Form: Solution for injection

İRONTU 500mg/25 ml



Active Ingredient: Irinotecan
Indication: Malignant diseases
Pharmaceutical Form: Solution for IV

Cytu 100 mg/ml



Active Ingredient: Cytarabine
Indication: Malignant diseases
Pharmaceutical Form: Solution for IV

Cytu 500 mg/5ml



Active Ingredient: Cytarabine
Indication: Malignant diseases
Pharmaceutical Form: Solution for IV

Cytu 1000 mg/10ml



Active Ingredient: Cytarabine
Indication: Malignant diseases
Pharmaceutical Form: Solution for IV

Docetu 20 mg/ml



Active Ingredient: Docetaxel
Indication: Malignant diseases
Pharmaceutical Form: Solution for IV

Docetu 80 mg/4 ml



Active Ingredient: Docetaxel
Indication: Malignant diseases
Pharmaceutical Form: Solution for IV

Mextu 5000 mg /50 ml



Active Ingredient: Methotrexate
Indication: Malignant diseases
Pharmaceutical Form: Solution for infusion (IM, IA, IV, IT)

Mextu 500 mg /20 ml



Active Ingredient: Methotrexate
Indication: Malignant diseases
Pharmaceutical Form: Solution for infusion (IM, IA, IV, IT)

Mextu 1000 mg/40 ml



Active Ingredient: Methotrexate
Indication: Malignant diseases
Pharmaceutical Form: Solution for infusion (IM, IA, IV, IT)

Alkyloaxan Inj. 200 mg



Active Ingredient: Cyclophosphamide
Indication: Malignant diseases
Pharmaceutical Form: Solution for IV

Alkyloaxan Inj. 500 mg



Active Ingredient: Cyclophosphamide
Indication: Malignant diseases
Pharmaceutical Form: Solution for IV

CYTARABINE Injection 100 mg



Active Ingredient: Cytarabine
Indication: Malignant diseases
Pharmaceutical Form: Powder and solvent for IV infusion

CYTARABINE Inj. 40 mg



Active Ingredient: Cytarabine
Indication: Malignant diseases
Pharmaceutical Form: Powder and solvent for IV infusion

UROKINASE-KGCC Inj. 500.000 IU Flakon



Active Ingredient: Urokinase
Indication: Malignant diseases
Pharmaceutical Form: Solution for injection

UROKINASE-KGCC Inj. 250.000 IU Flakon



Active Ingredient: Urokinase
Indication: Malignant diseases
Pharmaceutical Form: Solution for injection

5-FU Injection 250mg/5ml



Active Ingredient: 5-Fluoracil
Indication: Malignant diseases
Pharmaceutical Form: Solution for IV

KOPAQ 300 mgI/ML – 100 ml ve 50 ML



Active Ingredient: Iohexol
Indication: Contrast material for CT imaging
Pharmaceutical Form: Solution for infusion (IA, IV, intrathecal)

MESULID 100 mg tablet



Active Ingredient: Nimesulid
Indication: Antiinflammatory
Pharmaceutical Form: Oral suspension, and Tablet

Gadotu 287 mg/mL



Active Ingredient: Gadodiamid
Indication: Contrast material for MR imaging
Pharmaceutical Form: Solution for infusion

Kopaq 350 mg/ml



Active Ingredient: Iohexol
Indication: Contrast material for CT imaging
Pharmaceutical Form: Solution for infusion (IA, IV, intrathecal)

Pamintu 10 mg/ml



Active Ingredient: Protamine Sulphate
Indication: Heparin antagonist
Pharmaceutical Form: Solution for IV

Ravistu 300 mg



Active Ingredient: Iopromide
Indication: Contrast material for CT imaging
Pharmaceutical Form: Solution for infusion (IA, IV, intrathecal)

Ravistu 370 mg



Active Ingredient: Iopromide
Indication: Contrast material for CT imaging
Pharmaceutical Form: Solution for infusion (IA, IV, intrathecal)

Erastat 12.5 mg/ 50 mL



Active Ingredient: Tirofiban hydrochloride
Indication: Anticoagulant
Pharmaceutical Form: Solution for IV

Meksratu 25 mg/mL



Active Ingredient: Methotrexate
Indication: Antiinflammatory
Pharmaceutical Form: Prefilled syringe

Meksratu 20 mg/0,8mL



Active Ingredient: Methotrexate
Indication: Antiinflammatory
Pharmaceutical Form: Prefilled syringe

Meksratu 10 mg/0,4mL



Active Ingredient: Methotrexate
Indication: Antiinflammatory
Pharmaceutical Form: Prefilled syringe

Would you like to hear from us?

Subscribe our e- bulletin to receive news regarding recent developments
about oncology and Onko.